Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg BID versus clarithromycin 500 mg BID

Enright, 1994, Prevalence and correlates of respiratory symptoms and disease in the elderly. Cardiovascular Health Study, Chest, 106, 827, 10.1378/chest.106.3.827

1996, Morbidity and mortality, 5

1996, Morbidity and mortality, 49

Higgins, 1990, Incidence, prevalence, and mortality: Intra- and intercounty differences, 23

Petty, 1997, A new national strategy for COPD, J Respir Dis, 18, 365

Saint, 1995, Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis, JAMA, 273, 957, 10.1001/jama.1995.03520360071042

Balter, 1994, Recommendations on the management of chronic bronchitis: A practical guide for Canadian physicians, Can Med Assoc J, 10, 5

Ball, 1995, Epidemiology and treatment of chronic bronchitis and its exacerbations, Chest, 108, 43S, 10.1378/chest.108.2_Supplement.43S

Chodosh, 1992, Bronchitis and asthma, 476

Leeper, 1997, The changing bacterial etiology of chronic obstructive pulmonary disease (COPD), Presented at Chest 1997, 63rd Annual International Scientific Assembly of the American College of Chest Physicians

Doern, 1996, Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study, Antimicrob Agents Chemother, 40, 1208, 10.1128/AAC.40.5.1208

Doern, 1996, Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study, Antimicrob Agents Chemother, 40, 2884, 10.1128/AAC.40.12.2884

Doern, 1997, Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study, Antimicrob Agents Chemother, 41, 292, 10.1128/AAC.41.2.292

Flemingham, 1996, A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992–1993: The Alexander Project, J Antimicrob Chemother, 38, 1, 10.1093/jac/38.suppl_A.1

Gruneberg, 1996, Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens, Diagn Microbiol Infect Dis, 25, 169, 10.1016/S0732-8893(96)00135-6

Chodosh S, McCarty J, Farkas S, et al. Randomized, double-blind study of CIP and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis. In press.

Chodosh S, Schreurs A, Siami G, et al. Efficacy of oral ciprofloxacin vs CLA for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Infect Dis. In press.

Anzueto, 1997, Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: Interim analysis, Clin Ther, 19, 989, 10.1016/S0149-2918(97)80051-3

1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77

Anthonisen, 1987, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann Intern Med, 106, 196, 10.7326/0003-4819-106-2-196

1993

1993

Ball, 1998, Acute exacerbations of chronic bronchitis: An international comparison, Chest, 113, 199S, 10.1378/chest.113.3_Supplement.199S

Eller, 1998, Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function, Chest, 113, 1542, 10.1378/chest.113.6.1542

Chodosh, 1998, Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: Comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily, Antimicrob Agents Chemother, 42, 114, 10.1128/AAC.42.1.114

Baigelman, 1979, Quantitative sputum gram stains in chronic bronchial disease, Lung, 156, 265, 10.1007/BF02714020

Thornsberry, 1997, Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season, Diagn Microbiol Infect Dis, 29, 249, 10.1016/S0732-8893(97)00195-8

Siafakas, 1995, ERS consensus statement: Optimal assessment and management of chronic obstructive pulmonary disease (COPD), Eur Respir J, 8, 1398, 10.1183/09031936.95.08081398

Celli, 1995, ATS statement standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77

Jardim, 1997, Consenso Latinoamericano sobre infecciones en bronquitis crónica, Rev Panam Infectiol, 1, 7